(Q67993675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

H. Zimmermann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1487614

1 October 2022

J. Reichen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1487614

1 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1487614

1 October 2022

publication date

1 November 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

355-359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Prediction of risk in biliary surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

The identification of risk factors and their application to the management of obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Factors affecting mortality in biliary tract surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Pre-operative percutaneous transhepatic biliary drainage: The results of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high-performance thin-layer chromatography. I. Sample preparation, chromatography, and densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Protein and lipid disturbances in rat liver microsomal membranes after bile duct ligation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Abnormal lipid composition of microsomes from cirrhotic rat liver--does it contribute to decreased microsomal function?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Ursodeoxycholic acid therapy in the treatment of biliary atresia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Tauroursodeoxycholate prevents taurocholate induced cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980669-5

7 January 2021

10.1016/S0168-8278(05)80669-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1487614%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference